Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL1240885 (CGP-57380) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
BR serine/threonine kinase 2/BR serine/threonine-protein kinase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4574] [GtoPdb: 1947] [UniProtKB: Q8IWQ3] | ||||||||
ChEMBL | Inhibition of BRSK2 in the presence of 50uM ATP | B | 5.96 | pIC50 | 1100 | nM | IC50 | Biochem. J. (2007) 408: 297-315 [PMID:17850214] |
casein kinase 1 delta/Casein kinase I delta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2828] [GtoPdb: 1997] [UniProtKB: P48730] | ||||||||
ChEMBL | Inhibition of CK1delta in the presence of 20uM ATP | B | 6.29 | pIC50 | 510 | nM | IC50 | Biochem. J. (2007) 408: 297-315 [PMID:17850214] |
cyclin dependent kinase 9/CDK9/cyclin T1 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2111389] [GtoPdb: 1981] [UniProtKB: O60563, P50750] | ||||||||
ChEMBL | Inhibition of CDK9/cyclinT1 (unknown origin) using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis | B | 5 | pKi | >10000 | nM | Ki | Eur. J. Med. Chem. (2015) 103: 539-550 [PMID:26408454] |
cyclin dependent kinase 2/Cyclin-dependent kinase 2/cyclin A in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2094128] [GtoPdb: 1973] [UniProtKB: P20248, P24941, P78396] | ||||||||
ChEMBL | Inhibition of CDK2/cyclinA (unknown origin) using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis | B | 5 | pKi | >10000 | nM | Ki | Eur. J. Med. Chem. (2015) 103: 539-550 [PMID:26408454] |
dual specificity tyrosine phosphorylation regulated kinase 3/Dual-specificity tyrosine-phosphorylation regulated kinase 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4575] [GtoPdb: 2012] [UniProtKB: O43781] | ||||||||
ChEMBL | Inhibition of DYRK3 in the presence of 5uM ATP | B | 5.49 | pIC50 | 3200 | nM | IC50 | Biochem. J. (2007) 408: 297-315 [PMID:17850214] |
eukaryotic translation initiation factor 2 alpha kinase 2/Interferon-induced, double-stranded RNA-activated protein kinase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5785] [GtoPdb: 2016] [UniProtKB: P19525] | ||||||||
ChEMBL | Inhibition of human recombinant PKR autophosphorylation using poly[I:C] after 10 mins by luminescent assay | B | 5.3 | pIC50 | 5000 | nM | IC50 | Bioorg. Med. Chem. Lett. (2011) 21: 4108-4114 [PMID:21632247] |
MAPK interacting serine/threonine kinase 1/MAP kinase-interacting serine/threonine-protein kinase MNK1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4718] [GtoPdb: 2104] [UniProtKB: Q9BUB5] | ||||||||
ChEMBL | Inhibition of Mnk1 (unknown origin) pre-incubated for 10 mins before eIF4E peptide substrate addition by ADP-Glo kinase assay | B | 6 | pKi | 1010 | nM | Ki | Eur. J. Med. Chem. (2015) 95: 116-126 [PMID:25800647] |
ChEMBL | Inhibition of Mnk1a (unknown origin) using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis | B | 6 | pKi | 1010 | nM | Ki | Eur. J. Med. Chem. (2015) 103: 539-550 [PMID:26408454] |
ChEMBL | Inhibition of human MNK1 using CREBtide substrate by gamma-[32P]-ATP competitive inhibition assay | B | 5.56 | pIC50 | 2740 | nM | IC50 | Bioorg Med Chem (2019) 27: 2268-2279 [PMID:31014565] |
GtoPdb | - | - | 6.06 | pIC50 | 870 | nM | IC50 | J Med Chem (2010) 53: 6618-28 [PMID:20722422] |
ChEMBL | Inhibition of MKN1 (unknown origin) in presence of ATP by HTRF assay | B | 6.06 | pIC50 | 870 | nM | IC50 | J Med Chem (2021) 64: 13719-13735 [PMID:34515481] |
ChEMBL | Inhibition of MNK1 | B | 6.06 | pIC50 | 870 | nM | IC50 | J. Med. Chem. (2010) 53: 6618-6628 [PMID:20722422] |
ChEMBL | Inhibition of Mnk1a (unknown origin) using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis | B | 6.06 | pIC50 | 870 | nM | IC50 | Eur. J. Med. Chem. (2015) 103: 539-550 [PMID:26408454] |
ChEMBL | Inhibition of MNK1 in the presence of 50uM ATP | B | 6.06 | pIC50 | 870 | nM | IC50 | Biochem. J. (2007) 408: 297-315 [PMID:17850214] |
ChEMBL | Inhibition of MNK1 (unknown origin) expressed in HEK293 cells assessed as decrease in eIF4E phosphorylation at Ser209 residues by Western blot analysis | B | 6.06 | pIC50 | 870 | nM | IC50 | Eur J Med Chem (2019) 163: 413-427 [PMID:30530193] |
ChEMBL | Inhibition of MNK1 (unknown origin) using S3 as substrate measured after 60 mins by HTRF assay | B | 6.07 | pIC50 | 850 | nM | IC50 | Bioorg Med Chem (2018) 26: 4602-4614 [PMID:30115493] |
MAPK interacting serine/threonine kinase 2/MAP kinase signal-integrating kinase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4204] [GtoPdb: 2105] [UniProtKB: Q9HBH9] | ||||||||
ChEMBL | Inhibition of Mnk2 (unknown origin) pre-incubated for 10 mins before eIF4E peptide substrate addition by ADP-Glo kinase assay | B | 6.06 | pKi | 880 | nM | Ki | Eur. J. Med. Chem. (2015) 95: 116-126 [PMID:25800647] |
ChEMBL | Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis | B | 6.47 | pKi | 340 | nM | Ki | Eur. J. Med. Chem. (2015) 103: 539-550 [PMID:26408454] |
ChEMBL | Inhibition of MNK2 (unknown origin) | B | 5.8 | pIC50 | 1600 | nM | IC50 | Bioorg Med Chem (2018) 26: 4602-4614 [PMID:30115493] |
ChEMBL | Inhibition of MNK2 | B | 5.8 | pIC50 | 1600 | nM | IC50 | J. Med. Chem. (2010) 53: 6618-6628 [PMID:20722422] |
ChEMBL | Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 45 mins by ADP-Glo kinase assay | B | 5.8 | pIC50 | 1600 | nM | IC50 | Eur. J. Med. Chem. (2015) 103: 539-550 [PMID:26408454] |
ChEMBL | Inhibition of MNK2 in the presence of 50uM ATP | B | 5.8 | pIC50 | 1600 | nM | IC50 | Biochem. J. (2007) 408: 297-315 [PMID:17850214] |
ChEMBL | Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay | B | 5.8 | pIC50 | 1600 | nM | IC50 | J Med Chem (2021) 64: 13719-13735 [PMID:34515481] |
ChEMBL | Inhibition of MNK2 (unknown origin) expressed in HEK293 cells assessed as decrease in eIF4E phosphorylation at Ser209 residues by Western blot analysis | B | 5.8 | pIC50 | 1600 | nM | IC50 | Eur J Med Chem (2019) 163: 413-427 [PMID:30530193] |
GtoPdb | - | - | 5.8 | pIC50 | 1600 | nM | IC50 | J Med Chem (2010) 53: 6618-28 [PMID:20722422] |
ChEMBL | Inhibition of MNK2 (unknown origin) using S3 as substrate measured after 60 mins by HTRF assay | B | 5.82 | pIC50 | 1530 | nM | IC50 | Bioorg Med Chem (2018) 26: 4602-4614 [PMID:30115493] |
aurora kinase B/Serine/threonine-protein kinase Aurora-B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2185] [GtoPdb: 1937] [UniProtKB: Q96GD4] | ||||||||
ChEMBL | Inhibition of Aurora B in the presence of 20uM ATP | B | 5.6 | pIC50 | 2500 | nM | IC50 | Biochem. J. (2007) 408: 297-315 [PMID:17850214] |
serum/glucocorticoid regulated kinase 1/Serine/threonine-protein kinase Sgk1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2343] [GtoPdb: 1534] [UniProtKB: O00141] | ||||||||
ChEMBL | Inhibition of SGK1 in the presence of 20uM ATP | B | 5.57 | pIC50 | 2700 | nM | IC50 | Biochem. J. (2007) 408: 297-315 [PMID:17850214] |
ChEMBL | Inhibition of SGK1 | B | 5.57 | pIC50 | 2700 | nM | IC50 | J. Med. Chem. (2010) 53: 6618-6628 [PMID:20722422] |
LCK proto-oncogene, Src family tyrosine kinase/Tyrosine-protein kinase LCK in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2480] [GtoPdb: 2053] [UniProtKB: P06240] | ||||||||
ChEMBL | Inhibition of Lck in the presence of 50uM ATP | B | 5.6 | pIC50 | 2500 | nM | IC50 | Biochem. J. (2007) 408: 297-315 [PMID:17850214] |
ChEMBL data shown on this page come from version 31:
Gaulton A, Hersey A, Nowotka M, Bento AP, Chambers J, Mendez D, Mutowo P, Atkinson F, Bellis LJ, CibriƔn-Uhalte E, Davies M, Dedman N, Karlsson A, MagariƱos MP, Overington JP, Papadatos G, Smit I, Leach AR. (2017) 'The ChEMBL database in 2017.' Nucleic Acids Res., 45(D1). DOI: 10.1093/nar/gkw1074. [PMCID:5210557]